Torque'S Uditor 300 Tablets

Tablet

Oral

Each uncoated tablet contains:

• Ursodeoxycholic Acid I.P. 300 mg
• Excipients q.s.

Oral administration of ursodeoxycholic acid increases its fraction in a dose related manner, to become the major biliary acid, replacing/displacing toxic concentrations of endogenous hydrophobic bile acids that tend to accumulate in cholestatic liver disease. In addition to the replacement and displacement of toxic bile acids, other mechanisms of action include cytoprotection of the injured bile duct epithelial cells (cholangiocytes) against toxic effects of bile acids, inhibition of apoptosis of hepatocytes, immunomodulatory effects, and stimulation of bile secretion by hepatocytes and cholangiocytes.

Torque’s Uditor 300 Tablets are indicated in the treatment of patients with: Cholestatic liver disease, Primary biliary cholangitis, Primary biliary cirrhosis, Gallbladder stones

As directed by the physician.

Store at a temperature not exceeding 30°C, protect from light & moisture.

5 x 3 x 15 Tablets

Diarrhea Nausea/ vomiting Right upper abdominal pain Exacerbation of pruritus

Torque’s Uditor 300 Tablets are contraindicated in patients with a known allergy to bile acids or excipients, Patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula and patients with calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones are not candidates for Ursodeoxycholic acid therapy.

Torque’s Uditor 300 Tablets can cause drug interactions with the following drugs: Bile acid sequestering agents such as cholestyramine and colestipol; aluminium-based antacids; estrogens, oral contraceptives, and clofibrate (and perhaps other lipid-lowering drugs).